Wiem Lassoued

1.3k total citations · 1 hit paper
14 papers, 886 citations indexed

About

Wiem Lassoued is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wiem Lassoued has authored 14 papers receiving a total of 886 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wiem Lassoued's work include AI in cancer detection (3 papers), Angiogenesis and VEGF in Cancer (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Wiem Lassoued is often cited by papers focused on AI in cancer detection (3 papers), Angiogenesis and VEGF in Cancer (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Wiem Lassoued collaborates with scholars based in United States, Malaysia and Australia. Wiem Lassoued's co-authors include Badrinath Roysam, Yousef Al‐Kofahi, William M. F. Lee, Danielle Murphy, Michael D. Feldman, Gavin Thurston, Christopher Carter, Sosina Makonnen, Shaohua Chen and Ridha Oueslati and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Wiem Lassoued

14 papers receiving 863 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Improved Automatic Detection and Segmentation of Cell Nuclei in Histopathology Images

2009 509 citations Yousef Al‐Kofahi, Wiem Lassoued et al. IEEE Transactions on Biomedical Engineering profile →

Peers

Wiem Lassoued

AI

CVPR

MB

BIOPH

ONCOL

Daniel Heim Germany

Bassem Ben Cheikh France

Xiaojun Guan China

Ju Han United States

Peter D. Caie United Kingdom

Bartels Ph United States

Olcay Sertel United States

Guillaume Jaume United States

Lauri Goodell United States

António Polónia Portugal

Daniel Heim Germany

Wiem Lassoued

253 ×0.8

AI

159 ×0.5

CVPR

125 ×0.5

MB

115 ×0.5

BIOPH

84 ×0.5

ONCOL

Citations per year, relative to Wiem Lassoued Wiem Lassoued (= 1×) peers Daniel Heim

Countries citing papers authored by Wiem Lassoued

Since Specialization

Citations

This map shows the geographic impact of Wiem Lassoued's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wiem Lassoued with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wiem Lassoued more than expected).

Fields of papers citing papers by Wiem Lassoued

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wiem Lassoued. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wiem Lassoued. The network helps show where Wiem Lassoued may publish in the future.

Co-authorship network of co-authors of Wiem Lassoued

This figure shows the co-authorship network connecting the top 25 collaborators of Wiem Lassoued. A scholar is included among the top collaborators of Wiem Lassoued based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wiem Lassoued. Wiem Lassoued is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Lassoued, Wiem, et al.. (2025). Combination of HDAC inhibition and cytokine enhances therapeutic HPV vaccine therapy. Journal for ImmunoTherapy of Cancer. 13(5). e011074–e011074. 1 indexed citations

2.

Norberg, Scott M., John Davies, Wiem Lassoued, et al.. (2024). Adoptive transfer of membrane-restricted IL-12-TCR T cells promotes antigen spreading and elimination of antigen-negative tumor variants. Journal for ImmunoTherapy of Cancer. 12(11). e009868–e009868. 1 indexed citations

3.

Rajan, Arun, Houssein Abdul Sater, Osama E. Rahma, et al.. (2024). Efficacy, safety, and biomarker analyses of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with advanced non-small cell lung cancer. Journal for ImmunoTherapy of Cancer. 12(3). e008480–e008480. 9 indexed citations

4.

Sissung, Tristan M., Keith T. Schmidt, Jonathan D. Strope, et al.. (2023). GNRH2Polymorphism in Men With Prostate Cancer Treated With Androgen Deprivation Therapy. Anticancer Research. 43(9). 4023–4030. 1 indexed citations

5.

Dinstag, Gal, Leandro C. Hermida, Chani Stossel, et al.. (2023). Prediction of cancer treatment response from histopathology images through imputed transcriptomics.. Journal of Clinical Oncology. 41(16_suppl). 1551–1551. 3 indexed citations

6.

Robbins, Yvette, Wiem Lassoued, James L. Gulley, et al.. (2022). Multi-spectral immunofluorescence evaluation of the myeloid, T cell, and natural killer cell tumor immune microenvironment in chordoma may guide immunotherapeutic strategies. Frontiers in Oncology. 12. 1012058–1012058. 11 indexed citations

7.

Lassoued, Wiem, Antonios Papanicolau‐Sengos, Jennifer L. Marté, et al.. (2021). 420 PROSTVAC in combination with nivolumab enhanced immune cell infiltration in prostate cancer. SHILAP Revista de lepidopterología. A450–A450. 3 indexed citations

8.

Al‐Kofahi, Yousef, Wiem Lassoued, Sumit K. Nath, et al.. (2011). Cell-based quantification of molecular biomarkers in histopathology specimens. Histopathology. 59(1). 40–54. 26 indexed citations

9.

Lassoued, Wiem, Danielle Murphy, Jeff H. Tsai, et al.. (2010). Effect of VEGF and VEGF Trap on vascular endothelial cell signaling in tumors. Cancer Biology & Therapy. 10(12). 1326–1333. 38 indexed citations

10.

Al‐Kofahi, Yousef, et al.. (2009). Improved Automatic Detection and Segmentation of Cell Nuclei in Histopathology Images. IEEE Transactions on Biomedical Engineering. 57(4). 841–852. 509 indexed citations breakdown →

11.

Reid, Gregor S. D., Xiaochuan Shan, Christina Coughlin, et al.. (2009). Interferon-γ–Dependent Infiltration of Human T Cells into Neuroblastoma TumorsIn vivo. Clinical Cancer Research. 15(21). 6602–6608. 23 indexed citations

12.

Chen, Shaohua, Danielle Murphy, Wiem Lassoued, et al.. (2008). Activated STAT3 is a mediator and biomarker of VEGF endothelial activation. Cancer Biology & Therapy. 7(12). 1994–2003. 115 indexed citations

13.

Puttaswamy, Kanchan, Wiem Lassoued, Maryann Redlinger, et al.. (2007). Sorafenib targets BRAF and VEGFR in metastatic thyroid carcinoma. Journal of Clinical Oncology. 25(18_suppl). 6019–6019. 13 indexed citations

14.

Murphy, Danielle, Sosina Makonnen, Wiem Lassoued, et al.. (2006). Inhibition of Tumor Endothelial ERK Activation, Angiogenesis, and Tumor Growth by Sorafenib (BAY43-9006). American Journal Of Pathology. 169(5). 1875–1885. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact